Thrombosis and Haemostasis · 2009 · 39 citations · 21 references
MedicineHematologyPediatricsGood Laboratory PracticeHemostasisPediatric HematologyAnticoagulant TherapyAnticoagulation TherapyPediatric ThrombosisThrombosisThrombosis ManagementThrombosis PreventionMonitoring Of Anticoagulant TherapyPediatric Anticoagulation TherapyPoint Of Care MonitoringTherapeutic AnticoagulationThrombin Generation Assays
Point-of-care (POC) monitoring of oral anticoagulation has been widely adopted in both paediatric and adult patients. A new POC system, the CoaguChek XS has recently been developed to measure the international normalised ratio (INR) and may offer significant advantages. The CoaguChek XS utilises a new method of electrochemical clot detection based on thrombin generation. This system has not been previously evaluated in children with reference to the laboratory gold standard, the prothrombin time using reference thromboplastin. It was the objective to compare values obtained by the CoaguChek XS system with both the venous INR and the gold standard for anticoagulant monitoring, prothrombin time with reference thromboplastin (rTF/95). To evaluate the impact of testing using the CoaguChek XS on clinical anticoagulant dosing decisions. Fifty paired venous INR and capillary CoaguChek XS results were obtained from 31 children (aged up to 16 years). The laboratory gold standard, a manual prothrombin time with reference thromboplastin (rTF/95) was additionally performed on 26 samples. Correlation between the CoaguChek XS result and the venous INR was r = 0.810. Agreement between the CoaguChek XS result and the reference INR was shown to be higher (r=0.95), in the subset analysed by this method. Correlation between the venous INR and reference INR was r=0.90. Despite changes to the methodology of testing with the CoaguChek XS POC monitoring system, the accuracy of this method when compared with both the venous INR and gold standard reference INR was satisfactory. This resulted in infrequent changes to clinical decision making regarding anticoagulation.
21
A Concordance Correlation Coefficient to Evaluate Reproducibility
Biometrics · 1989 · 8.7K citations
Pharmacology and Management of the Vitamin K Antagonists
Jack Ansell, Jack Hirsh, Elaine M. Hylek et al. · CHEST Journal · 2008 · 2.1K citations
The Pharmacology and Management of the Vitamin K Antagonists
Jack Ansell, Jack Hirsh, L. Poller et al. · CHEST Journal · 2004 · 1.5K citations
Development of the human coagulation system in the full-term infant
M Andrew, Bosco Paes, Ruth Milner et al. · Blood · 1987 · 1.2K citations · Full text
Medicine, Pediatrics, Physiology +14